Zhao, Xue
Xie, Han
Shao, Tengfei
Ge, Weihong
Zhu, Yizhun
Jin, Ziyi
Sun, Lingyun
Funding for this research was provided by:
Jiangsu Pharmaceutical Association: AOSAIKANG Hospital Pharmacy Research Project (A202512)
the Joint Fund of the National Natural Science Foundation of China (U24A20380 to L.S.)
and the Key Projects of the Jiangsu Basic Research Program (BK20243061 to L.S.)
Article History
Received: 12 January 2026
Accepted: 8 April 2026
First Online: 17 April 2026
Declarations
:
: This study involves human participants and was approved by the Ethics Committee of Nanjing Drum Tower Hospital (approval number: 2021-643-02). Participants gave informed consent to participate in the study before taking part, and the Declaration of Helsinki guidelines were followed.
: Not applicable.
: The authors declare no competing interests.